Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Low-Dose Stereotactic Radiotherapy Targeting the Subgenual Anterior Cingulate Cortex for Treatment-Resistant Depression: Study Protocol for a Dose-Exploratory, Parallel-Controlled Trial

NCT07274917 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07274917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Low-Dose Stereotactic Radiotherapy Targeting the Subgenual Anterior Cingulate Cortex for Treatment-Resistant Depression: Study Protocol for a Dose-Exploratory, Parallel-Controlled Trial
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2026
Completion date
June 30, 2026
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, treatment-resistant depression